BMY
BRISTOL MYERS SQUIBB CO
Latest Form 4:Sale$34KbyHolzer Phil M (SVP and Controller) · filed Aug 26, 2026
BRISTOL MYERS SQUIBB CO (BMY) has 28 SEC Form 4 filings (138 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Aug 26, 2026.
Insiders have net sold $1.9M over the trailing 6 months.
- Industry:Drug Manufacturers - General
- CEO:Christopher S. Boerner
- Employees:34,100
- HQ:Princeton, NJ, US
- IPO:1972-06-01
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.5M
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$136.0B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Holzer Phil MFirst filing | SVP and Controller | Sale | 500 | $34K | Aug 26 | SEC ↗ |
Elkins David VFirst in 7 months | EVP, Chief Financial Officer | Sale | 30,000 | $1.9M | Apr 2 | SEC ↗ |
Elkins David VFirst filing | EVP, Chief Financial Officer | Sale | 56,000 | $2.7M | Sep 3 | SEC ↗ |
Congress trading BMY
See timeline →- RSen. Tommy TubervilleSale$1,001 - $15,0002025-04-15
- RRep. Mike KellySale$15,001 - $50,0002026-05-07
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Related companies
BRISTOL MYERS SQUIBB CO is in the Healthcare sector.